Title: | Early diagnosis and screening in lung cancer |
Author(s): | Cainap C; Pop LA; Balacescu O; Cainap SS; |
Address: | "Department of Oncology, 'Iuliu Hatieganu' University of Medicine and Pharmacy Cluj-Napoca, Romania. Prof. Dr. Ion Chiricuta Institute of Oncology Cluj-Napoca, Romania. Research Center for Functional Genomics, Biomedicine and Translational Medicine, University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca, Romania. Department of Functional Genomics and Experimental Pathology, Prof. Dr. Ion Chiricuta Institute of Oncology Cluj-Napoca, Romania. Department of Pediatric Cardiology, Emergency County Hospital for Children, Pediatric Clinic no 2 Cluj-Napoca, Romania. Department of Mother and Child, 'Iuliu Hatieganu' University of Medicine and Pharmacy Cluj-Napoca, Romania" |
ISSN/ISBN: | 2156-6976 (Print) 2156-6976 (Electronic) 2156-6976 (Linking) |
Abstract: | "Lung cancer is the third most diagnosed cancer, but the first cause of cancer-related deaths worldwide. This rather high death rate is due mainly to the fact that most patients are diagnosed with advanced-stage cancer, for which the conventional treatment does not work. The most used screening method for lung cancer is a low-dose CT scan, but it is recommended for specific age populations and it also started different debates on its advantages for lung cancer diagnosis. Over the year, several new techniques have been developed that are less invasive, have lower side effect, and can be implemented at all types of populations. This article aimed to present the advantages and disadvantages of using several methods for lung cancer diagnosis, including analysis of volatile organic compounds, exhaled breath condensate analysis and specific genomic approaches" |
Keywords: | Lung cancer early diagnosis exhaled breath condensate genomic approaches volatile organic compounds; |
Notes: | "PubMed-not-MEDLINECainap, Calin Pop, Laura A Balacescu, Ovidiu Cainap, Simona S eng Review 2020/08/11 Am J Cancer Res. 2020 Jul 1; 10(7):1993-2009. eCollection 2020" |